Kidney Cancer

Microwave Ablation May Be Safe Alternative to Partial Nephrectomy

Publish Date September 15, 2023

A retrospective study revealed no significant difference in 36-month progression-free survival and renal function outcomes in patients with small renal masses.

Bariatric Surgery Linked to Lower All-Cancer Incidence Among Females

Publish Date September 6, 2023

Significant reduction also seen in obesity-related cancer incidence and in cancer mortality after bariatric surgery

New-Onset Hypertension Frequent After Nephrectomy

Publish Date August 28, 2023

Clinicians should closely monitor patients’ blood pressure after nephrectomy, according to investigators.

Lymphovascular Invasion Ups Mortality Risk in Kidney Cancer Surgery Cases

Publish Date August 25, 2023

Investigators believe their study is the first to demonstrate the adverse impact of LVI on overall survival in patients with surgically treated renal cell carcinoma.

Higher Cardiorespiratory Fitness Protects Men Against Many Cancers

Publish Date August 21, 2023

Benefits seen for head/neck, stomach, pancreatic, liver, colon, kidney, and lung cancer

New Tool Promises Improved Patient Selection for Cytoreductive Nephrectomy

Publish Date August 11, 2023

In a study, the Selection for Cytoreductive Nephrectomy (SCREEN) score demonstrated superiority in predicting first-year mortality among patients with metastatic kidney cancer compared with an IMDC model.

Equation Predicts Kidney Failure After Nephrectomy

Publish Date August 9, 2023

The Kidney Cancer Risk Equation for predicting post-nephrectomy ESKD builds on the ubiquitous Kidney Failure Risk Equation and is easy to use, according to investigators.

Hypertension Risk Lower in Younger Sunitinib, Sorafenib Recipients With RCC

Publish Date August 2, 2023

A study revealed no significant difference in the incidence of left ventricular systolic dysfunction between patients aged 18-39 years and older patients.

ASCO 2023: Improving Genitourinary Cancer Care

Publish Date July 24, 2023

At ASCO 2023, investigators reported results from phase 3 trials that could improve therapeutic approaches to bladder, prostate, and kidney cancer.

Pharmacy-Level Stewardship Can Save on Immune Checkpoint Inhibitors

Publish Date July 24, 2023

Strategies include dose rounding and vial sharing, as well as weight-based dosing